Antisense modulation of Smad7 expression

Details Antisense modulation of Smad7 expression Antisense modulation of Smad7 expression

2000-01-09

2000-12-12

Schwartzman, Robert A.

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

536 231, 536 245, 435325, C12Q 168

Patent

active

061596973

ABSTRACT:
Antisense compounds, compositions and methods are provided for modulating the expression of Smad7. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Smad7. Methods of using these compounds for modulation of Smad7 expression and for treatment of diseases associated with expression of Smad7 are provided.

REFERENCES:
patent: 5789573 (1998-08-01), Baker et al.
Afrakhte et al., Induction of inhibitory smad6 and smad7 mRNA by TGF-beta family members [In Process Citation], Biochem. Biophys. Res. Commun. , 1998, 249:505-511.
Hayashi et al., The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling, Cell , 1997, 89:1165-1173.
Heldin et al., TGF-beta signalling from cell membrane to nucleus through SMAD proteins, Nature , 1997, 390:465-471.
Ishisaki et al., Smad7 Is an Activin-inducible Inhibitor of Activin-induced Growth Arrest and Apoptosis in Mouse B Cells, J. Biol. Chem. , 1998, 273:24293-24296.
Kretzschmar et al., SMADs: mediators and regulators of TGF-beta signaling, Curr. Opin. Genet. Dev. , 1998, 8:103-111.
Nakao et al., Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling [see comments], Nature , 1997, 389:631-635.
Takase et al., Induction of Smad6 mRNA by bone morphogenetic proteins, Biochem. Biophys. Res. Commun. , 1998, 244:26-29.
Topper et al., Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium, Proc. Natl. Acad. Sci. U. S. A. , 1997, 94:9314-9319.
Topper et al., Expression of the bumetanide-sensitive Na-K-Cl cotransporter BSC2 is differentially regulated by fluid mechanical and inflammatory cytokine stimuli in vascular endothelium, J. Clin. Invest. , 1997, 99:2941-2949.
Wrana, TGF-beta receptors and signalling mechanisms, Miner. Electrolyte Metab. , 1998, 24:120-130.
Branch, A good antisense molecule is hard to find, TIBS, vol. 23, pp. 45-50, Feb. 1998.
Agrawal, Antisense oligonucleotides:towards clinical trails, TIBTECH, vol. 14, pp. 376-387, Oct. 1996.
Gewirtz et al., Facilitating oligonucleotide delivery: helping anitsense deliver on its promise, PNAS, vol. 93, pp. 3161-3163, Apr. 1996.
Sanghvi, Heterocyclic base modifications in nucleic acids and their applications in antisense oligonucleotides, Antisense Research and Applications, pp. 273-288, 1993.

Affiliated with

Also associated with

Rating

Antisense modulation of Smad7 expression does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antisense modulation of Smad7 expression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense modulation of Smad7 expression will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-215424